AGM and IMS

Stanelco PLC 28 April 2008 28th April 2008 Stanelco plc ('Stanelco' or the 'Company') AGM Statement and Interim Management Statement The Company's Annual General Meeting will take place at 10am today at the offices of Financial Dynamics, Holborn Gate, 26 Southampton Buildings, London WC2A 1PB. The following comments will be made regarding current trading, financial performance and outlook for the financial year. This statement covers the period 1 January 2008 to the date of this announcement and constitutes Stanelco's first Interim Management Statement as required by the UK Listing Authority's Disclosure and Transparency Rules. Current Trading The 2008 financial year has started well and in line with the expectations indicated in the 2007 Annual Report. Current sales from Biotec are in line with Board expectations and the Stanelco Bioplastics team have begun to achieve some encouraging sales traction in a number of end-user areas. The market remains fast-moving, driven as it is by both changing legislative and consumer requirements. We are concentrating on adapting and enhancing the functional and commercial attributes of bioplastic materials which will be essential to commercial success. Development trials at the bioplastic pilot unit, commissioned recently in the Company's UK facility, have started and an expansive set of trials are underway. This unit is now being strengthened with the recruitment of further scientific staff. Stanelco RF Applications is continuing to develop its product range and has a strong enquiries book. Sales are in line with Board expectations and last year. Financial Performance At 31st March we had cash of £7.5m and continue to consider sensible investment opportunities for these funds. Outlook We expect continued good progress in the Company's main businesses. This gives the Board confidence in the outlook for further commercialisation and development in 2008. For further information please contact: Financial Dynamics Jonathon Brill/Caroline Stewart Tel: +44 (0) 207 831 3113 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings